Relapsing neuromyelitis optica: Long term history and clinical predictors of death

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 10, 2009, Pages 1162-1164

  Cabre, P ^a   Gonzalez Quevedo A ^b   Bonnan, M ^a   Saiz, A ^c   Olindo, S ^a   Graus, F ^c   Smadja, D ^a   Merle, H ^a   Thomas, L ^a   Cabrera Gomez, J A ^d,e  

^a Pierre Zobda Quitman Hospital   (Martinique)

^b INSTITUTO DE NEUROLOGÍA Y NEUROCIRUGÍA   (Cuba)

^c UNIVERSITY OF BARCELONA   (Spain)

^d Cuban Multiple Sclerosis Society   (Cuba)

^e CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; MITOXANTRONE; RITUXIMAB;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANAMNESIS; ARTICLE; BLINDNESS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; COURSE EVALUATION; DISABILITY SEVERITY; DISEASE DURATION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; RECURRENCE RISK; SCHOOL CHILD; SEX DIFFERENCE; VISUAL IMPAIRMENT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; COHORT STUDIES; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; RECOVERY OF FUNCTION; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 70349690304     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.143529     Document Type: Article

References (19)

1. Wingerchuk D, Weinshenker B. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 2003;60:848-853 (Pubitemid 36297372)
2. Ghezzi A, Bergamashi R, Martinelli V, et al. Clinical characteristics, course and prognosis of relapsing Devic's neuromyelitis optica. J Neurol 2004;251:47-52. (Pubitemid 38210489)
3. Cabre P, Signate A, Olindo S, et al. Role of return migration in the emergence of multiple sclerosis in the French West Indies. Brain 2005;128:2899-2910 (Pubitemid 41746643)
4. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-1489
5. Saiz A, Zuliani L, Blanco Y, et al. Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients. J Neurol 2007;254:1233-1237 (Pubitemid 350112363)
6. O'Riordan JI, Gallagher HL, Thompson AJ, et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 1996;60:382-387 (Pubitemid 26118744)
7. Mandler RN, Davies LE, Jeffery DR, et al. Devic's neuromyelitis optica: a clinical pathological study of 8 patients. Ann Neurol 1993;34:162-168 (Pubitemid 23223043)
8. Yamasaki K, Horiuchi I, Minohara M. HLA-DPB1*0501-associated opticospinal multiple sclerosis. Clinical, neuroimaging and immunogenetic studies. Brain 1999;122:1689-1696
9. De Seze J, Lebrun C, Stojkovic T, et al. Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis. Mult Scler 2003;9:521-525 (Pubitemid 37287734)
10. Papais-Alvarenga RM, Carellos RC, Alvarenga RP, et al. Clinical course of optic neuritis in patients with relapsing neuromyelitis optica. Arch Ophthalmol 2008;126:12-16.
11. Jarius S, Franciotta D, Bergamaschi H, et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology 2007;68:1076-1077
12. Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007;130:1206-1223 (Pubitemid 47355945)
13. Keegan M, Pineda A, McClelland R, et al. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002;58:143-146 (Pubitemid 34041955)
14. Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 1998;51:1219-1220 (Pubitemid 28473439)
15. Cree BA, Lamb S, Morgan K, et al. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 2005;64:1270-1272 (Pubitemid 40490534)
16. Weinstock-Guttman B, Ramanathan R, Lincoff N, et al. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic's disease). Arch Neurol 2006;63:957-963 (Pubitemid 44036296)
17. Papeix C, Vidal JS, De Seze J, et al. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler 2007;13:256-259 (Pubitemid 46592781)
18. Weinshenker BJ, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2005;59:566-569 (Pubitemid 43358081)
19. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007;6:805-815